Local companies will be connected to over 200 global and national biotech investors at Australia Biotech Invest 2017 in Melbourne – Australia’s biotechnology centre.
The Andrews Labor Government is backing the conference, which cements Victoria’s reputation as a world-leading location to develop and manufacture medical technologies, biotechnologies and pharmaceuticals.
Victoria is one of the world’s leading biotechnology hubs and the centre of Australia’s biotech investment with over 650 companies, 10 major medical research institutes, 10 major teaching hospitals and nine universities.
The state’s booming biotechnology, medical technology and pharmaceutical sector employs more than 23,000 people and generates over $12.7 billion in revenue.
It contributes over $1.35 billion in exports to the Victorian economy – more than double what it did six years ago.
Australia Biotech Invest provides the opportunity for global investors to tap into Victoria’s expanding clinical trials market, as well as its infectious diseases and diagnostics, cancer, regenerative medicine, medtech and neuroscience research.
Last year Australia was named fourth in the world in the Scientific American Worldview: A Global Biotechnology Perspective – which evaluates the biotechnology innovation capacities of countries around the globe.
Quotes attributable to Minister for Innovation and the Digital Economy Philip Dalidakis
“We’re proud to host the Australia Biotech Invest conference again and cement Victoria’s place as the centre of biotech research and development in Australia.”
“These sectors will be a crucial part of our future economy and we’ll continue to encourage further investment and create more jobs.”
Quotes attributable to Parliamentary Secretary for Innovation and Small Business Frank McGuire
“Australia BioTech Invest allows Melbourne to showcase the world leading research and advanced manufacturing that make our state so attractive to global companies.”
“We have been a long term supporter of this event because it gives local companies the opportunity to connect with investors from Australia and around the world.”
Reviewed 19 August 2020